Trial Profile
Compassionate Use of SOM230 for Individual Patient (NS, 14-Jan-1986) With Hyperinsulinemic/Hypoglycemia
Status:
Recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 01 Aug 2022
Price :
$35
*
At a glance
- Drugs Pasireotide (Primary)
- Indications Hypoglycaemia
- Focus Expanded access; Therapeutic Use
- 20 Jul 2016 New trial record